Recognizing and treating endometriosis

Area of Science:

• Reproductive Medicine
• Gynecology
• Chronic Disease Management

Background:

• Endometriosis is a prevalent condition affecting 10% of reproductive-aged women globally.
• Ectopic endometrial tissue causes chronic inflammation, pain, and subfertility.
• Delayed diagnosis is common, impacting women's quality of life.

Purpose of the Study:

• To review the epidemiology, pathophysiology, and clinical presentation of endometriosis.
• To discuss current and emerging treatment options for women desiring or not desiring pregnancy.
• To highlight the novel oral gonadotropin-releasing hormone (GnRH) antagonist, elagolix.

Main Methods:

• Literature review of endometriosis epidemiology, pathophysiology, and clinical manifestations.
• Analysis of treatment strategies for various patient populations.
• Inclusion of data on elagolix, a new GnRH antagonist.

Main Results:

• Endometriosis is characterized by hormonally responsive ectopic tissue leading to inflammation and symptoms.
• Subfertility is a common consequence of the disease.
• Elagolix represents a new therapeutic avenue for endometriosis management.

Conclusions:

• Comprehensive understanding of endometriosis is crucial for timely diagnosis and effective management.
• Treatment approaches should be tailored to individual patient needs and fertility desires.
• Elagolix offers a promising new oral treatment option for endometriosis.